328 related articles for article (PubMed ID: 19011856)
1. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.
Testa U
Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic induction of fetal hemoglobin production.
Atweh G; Fathallah H
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1131-44. PubMed ID: 21075284
[TBL] [Abstract][Full Text] [Related]
3. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
4. Disorders of the synthesis of human fetal hemoglobin.
Manca L; Masala B
IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
[TBL] [Abstract][Full Text] [Related]
5. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
6. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B
Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
[TBL] [Abstract][Full Text] [Related]
7. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
[TBL] [Abstract][Full Text] [Related]
9. Modifier genes in Mendelian disorders: the example of hemoglobin disorders.
Sankaran VG; Lettre G; Orkin SH; Hirschhorn JN
Ann N Y Acad Sci; 2010 Dec; 1214():47-56. PubMed ID: 21039591
[TBL] [Abstract][Full Text] [Related]
10. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation.
Amoyal I; Prus E; Fibach E
Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of fetal hemoglobin by BCL11A.
Sankaran VG; Xu J; Orkin SH
Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774
[TBL] [Abstract][Full Text] [Related]
12. Fetal globin induction in beta-thalassemia.
El-Beshlawy A; Hamdy M; El Ghamrawy M
Hemoglobin; 2009; 33 Suppl 1():S197-203. PubMed ID: 20001626
[TBL] [Abstract][Full Text] [Related]
13. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
Pace BS; Zein S
Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
15. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
Cui S; Engel JD
Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin switching and its clinical implications.
Blau CA; Stamatoyannopoulos G
Curr Opin Hematol; 1994 Mar; 1(2):136-42. PubMed ID: 9371272
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
20. Role of intergenic human gamma-delta-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells.
Bank A; O'Neill D; Lopez R; Pulte D; Ward M; Mantha S; Richardson C
Ann N Y Acad Sci; 2005; 1054():48-54. PubMed ID: 16339651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
